Inozyme Pharma, Inc.
USD4.00
+0.01 (+0.25%)
CEO
Douglas A. Treco
IPO Date
2020-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.00
Prev. Close
$4.00
Day Low
$4.00
Day High
$4.00
52W Low
$0.72
52W High
$6.24
Market Cap
$0.26B
Volume
1.46M
| -3.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -55.2% | -47.0% | 0.06 | 8.93 | -0.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -51.6% | -45.7% | 0.03 | 9.92 | -2.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -35.3% | -33.0% | 0.01 | 15.14 | -8.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 56.0% | -38.8% | 0.00 | 14.67 | -14.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 50.2% | -16.0% | 0.00 | 18.11 | -38.1 |
| -1.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -29.7% | -17.1% | 0.58 | 7.68 | -3.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -28.6% | -17.4% | 0.49 | 9.84 | -2.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -19.6% | -13.2% | 0.39 | 14.05 | -4.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -15.3% | -10.7% | 0.33 | 13.36 | -3.1 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -10.4% | -8.1% | 0.21 | 16.36 | -3.6 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -14.8% | -10.3% | 0.32 | 11.89 | -4.0 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -15.7% | -11.4% | 0.26 | 10.66 | -3.9 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -15.7% | -13.3% | 0.06 | 8.93 | -0.6 |